Heart disease. Hearing loss. Addiction. Chronic pain. Alzheimer's. ALS. These are some of the areas where Eli Lilly, flush with cash from its GLP-1 drugs, wants to make big bets. These are the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback